Identification of the Tyrosine-Protein Phosphatase Non-Receptor Type 2 as a Rheumatoid Arthritis Susceptibility Locus in Europeans

Objectives Genome-wide association studies have facilitated the identification of over 30 susceptibility loci for rheumatoid arthritis (RA). However, evidence for a number of potential susceptibility genes have not so far reached genome-wide significance in studies of Caucasian RA. Methods A cohort of 4286 RA patients from across Europe and 5642 population matched controls were genotyped for 25 SNPs, then combined in a meta-analysis with previously published data. Results Significant evidence of association was detected for nine SNPs within the European samples. When meta-analysed with previously published data, 21 SNPs were associated with RA susceptibility. Although SNPs in the PTPN2 gene were previously reported to be associated with RA in both Japanese and European populations, we show genome-wide evidence for a different SNP within this gene associated with RA susceptibility in an independent European population (rs7234029, P = 4.4×10−9). Conclusions This study provides further genome-wide evidence for the association of the PTPN2 locus (encoding the T cell protein tyrosine phosphastase) with Caucasian RA susceptibility. This finding adds to the growing evidence for PTPN2 being a pan-autoimmune susceptibility gene.

[1]  Eli Stahl,et al.  High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis , 2012, Nature Genetics.

[2]  Hideo Tanaka,et al.  Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population , 2012, Nature Genetics.

[3]  A. Barton,et al.  Clinical and epidemiological research , 2011 .

[4]  A. Barton,et al.  Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap , 2012, Annals of the rheumatic diseases.

[5]  A. Weiss,et al.  Unraveling the functional implications of GWAS: how T cell protein tyrosine phosphatase drives autoimmune disease. , 2011, The Journal of clinical investigation.

[6]  K. Siminovitch,et al.  Fine mapping the TAGAP risk locus in rheumatoid arthritis , 2011, Genes and Immunity.

[7]  M. Brown,et al.  Promise and pitfalls of the Immunochip , 2011, Arthritis research & therapy.

[8]  C. Langefeld,et al.  The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. , 2010, Arthritis and rheumatism.

[9]  Jing Cui,et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.

[10]  M. Daly,et al.  Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk , 2009, Nature Genetics.

[11]  R. Sen,et al.  Faculty Opinions recommendation of REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. , 2009 .

[12]  Larry W. Moreland,et al.  REL, a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis , 2009, Nature Genetics.

[13]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[14]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[15]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[16]  F. Arnett Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[17]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[18]  C. Werning [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.